Atlas Trials

IBI188 Combination Therapy in Solid Tumors

Clinical trial NCT04861948 · TERMINATED

Trial details

NCT number
NCT04861948
Sponsor
Innovent Biologics (Suzhou) Co. Ltd.
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid TumorsLung AdenocarcinomaOsteosarcoma
Start date
2021-05-25
Primary completion
2022-07-30
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.